Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modigraf in Paediatric Solid Allograft Recipients
NCT01371344Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Jun 2011
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 4 trial of Envarsus XR in heart transplant rejection, kidney transplant rejection, Liver transplant rejection, sponsored by Astellas Pharma. Started Jun 2011; status: terminated.
02
Drugs
Envarsus XR
03
Conditions
heart transplant rejectionkidney transplant rejectionLiver transplant rejection
Beyond the preview
Go deeper on NCT01371344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371344.